1. Home
  2. HSDT vs ADN Comparison

HSDT vs ADN Comparison

Compare HSDT & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • ADN
  • Stock Information
  • Founded
  • HSDT N/A
  • ADN 2006
  • Country
  • HSDT United States
  • ADN United States
  • Employees
  • HSDT 21
  • ADN N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ADN Power Generation
  • Sector
  • HSDT Health Care
  • ADN Utilities
  • Exchange
  • HSDT Nasdaq
  • ADN Nasdaq
  • Market Cap
  • HSDT 4.2M
  • ADN 4.9M
  • IPO Year
  • HSDT N/A
  • ADN N/A
  • Fundamental
  • Price
  • HSDT $5.94
  • ADN $4.55
  • Analyst Decision
  • HSDT Hold
  • ADN
  • Analyst Count
  • HSDT 1
  • ADN 0
  • Target Price
  • HSDT N/A
  • ADN N/A
  • AVG Volume (30 Days)
  • HSDT 993.8K
  • ADN 2.1M
  • Earning Date
  • HSDT 08-14-2025
  • ADN 08-12-2025
  • Dividend Yield
  • HSDT N/A
  • ADN N/A
  • EPS Growth
  • HSDT N/A
  • ADN N/A
  • EPS
  • HSDT N/A
  • ADN N/A
  • Revenue
  • HSDT $295,000.00
  • ADN $115,000.00
  • Revenue This Year
  • HSDT N/A
  • ADN $6,528.51
  • Revenue Next Year
  • HSDT $75.13
  • ADN N/A
  • P/E Ratio
  • HSDT N/A
  • ADN N/A
  • Revenue Growth
  • HSDT N/A
  • ADN N/A
  • 52 Week Low
  • HSDT $5.37
  • ADN $1.71
  • 52 Week High
  • HSDT $1,200.00
  • ADN $8.79
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 24.77
  • ADN 79.07
  • Support Level
  • HSDT $5.75
  • ADN $1.85
  • Resistance Level
  • HSDT $6.04
  • ADN $1.95
  • Average True Range (ATR)
  • HSDT 0.43
  • ADN 0.52
  • MACD
  • HSDT 2.01
  • ADN 0.22
  • Stochastic Oscillator
  • HSDT 22.88
  • ADN 46.61

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space, including liquid hydrogen carriers such as methanol. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: